Blog

Your blog category

How Linezolid’s Structure Shapes Its Antibacterial Activity

Approved by the FDA in 2000, Linezolid introduced the oxazolidinone class into clinical practice. Its activity against susceptible Gram-positive pathogens, including methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant enterococci (VRE), made it useful where established antibiotics faced resistance. Its molecular architecture helps explain how it engages the bacterial ribosome. Three Parts of One Molecule The Linezolid

How Linezolid’s Structure Shapes Its Antibacterial Activity Read More »